BRITISH SOCIETY FOR HAEMATOLOGY

65th Annual Scientific Meeting

 

27-29 April Glasgow
Close
N. Poster
Poster title
Applicant name
Status
  1-EP Post Transplant Cyclophosphamide as a Cost Effective Innovation to Advance Transplantation in Advanced Hematological Malignancies. Mohmad Shahnawaz Beg Received Received
  3-EP Diagnostic utility of Whole genomic sequencing in acute leukaemia DANUSHKA DISSANAYAKA Received Received
  5-EP Prevalence of IKZF1 deletions in Tunisian pediatric acute lymphoblastic leukemia Rim Frikha Received Received
  6-EP Targeting Senescence as a Promising Therapy for Chemoresistance in Paediatric Acute Myeloid Leukaemia Aya Gouma Received Received
  8-PP Empagliflozin Impact on Outcomes of -Thalassemia Major Patients With Type 2 Diabetes: The THALEMPA Study Anas Ibraheem Received Received
  8-EP Improving Patient Experience and Hospital Efficiency through Ambulatory Care in SCT/CAR-T Treatment Rebecca Hallam Received Received
  9-EP Surge in Acute Promyelocytic Leukaemia Cases Presenting to University Hospitals of North Midlands: Population-based analysis Romario Hamid Received Received
  10-EP Platelet support in patients receiving different types of allogeneic haematopoietic stem cell transplants. Orna hogan Received Received
  11-EP Real-World Treatment Patterns and Outcomes in AML Patients Treated with Venetoclax in Great Britain (ARC) Sophie Barnwell Received Received
  13-EP Philadelphia Positive ALL - Transplant v No Transplant a 10 Year West Of Scotland Review steven leak Received Received
  14-EP Ten Years of T-Cell Acute Lymphoblastic Leukaemia/Lymphoma (T-ALL/LBL) - A West of Scotland Perspective steven leak Received Received
  15-PO Pulmonary Vein Thrombosis in a pregnant woman known to have SLE and Factor XI deficiency Zain Khan Tareen Received Received
  15-EP Childhood B-cell lymphoblastic leukemia accompanied by intrachromosomal amplification of chromosome 21:case report and literature review Jiantuo Liu Received Received
  16-EP Real World Outcomes of AML Patients with flt3 mutations using Midostaurin as per Ratify protocol. Deepak Mannari Received Received
  17-EP The development of a womens health clinic for women post stem cell transplant Maria Mazza Received Received
  20-EP Moving Cycle 1 of Venetoclax/Azacytadine (Ven/Aza) to Ambulatory Care (AC) Sarah Mohamed Received Received
  21-EP Stem Cell Transplantation As A Therapeutic Approach In Pediatric Refractory Leukemia: A Case Study Purshotam Paudel Received Received
  22-EP A Case of Near-ETP-ALL in an Adult: Diagnostic Nuances and Multidisciplinary Insights Milly Payne Received Received
  23-EP A single center experience in AML registry-pilot phase Walaa Saad Received Received
  24-EP QuANTUM-Wild: Phase 3, Randomized, Double-Blind Quizartinib Study in Newly Diagnosed, FLT3-ITDNegative Acute Myeloid Leukemia Heather Hubbard Received Received
  25-EP Revised 2024 ELN Risk Classifications in Low-Intensity AML: Do they help in the real world? Cristina M. Thiebaud Received Received
  26-EP Chromosomal abnormalities during the clinical course of Acute Leukemia ZOTOVA OLENA Received Received
  28-EP Therapeutic Impact of BET Inhibition on Immune Cell Death Checkpoints in MPN Niloofar Amirian Received Received
  29-EP Toxic Epidermal Necrolysis: A Rare Cutaneous Adverse Reaction To Lenalidomide Ciara Bansal Received Received
  30-EP Bomedemstat Versus Hydroxyurea in Essential Thrombocythemia Naive to Cytoreductive Therapy: Phase 3 Shorespan-007 Study Charlotte Brennan Received Received
  31-EP A rare paediatric case of myeloid/lymphoid neoplasm with platelet-derived growth factor receptor beta (PDGFRB) rearrangement Joanna Fawcett Received Received
  32-EP Metabolism of Amino Acids as a Therapeutic Target and Predictor of Leukaemia Patient Outcome Elena-Simona Gheban Received Received
  34-EP Cutaneous Manifestation of a Rare Haematological Malignancy: Blastic Plasmacytoid Dendritic Cell Neoplasm Syeda Liaba Hassan Received Received
  35-EP Modifying Cardiovascular risk factors for patients on Tyrosine Kinase Inhibitors: sharing our improved practice Anna Elliott Received Received
  36-EP Gender and Treatment Impact on Chronic Myeloid Leukaemia Outcomes: Patient-Reported Outcomes and Wearable Data Insights Ashley Lai Received Received
  37-EP Outcomes in patients with Advanced phase Myeloproliferative Neoplasm treated with Ruxolitinib and 5-Azacytidine combination therapy Wai Ka Natalie Leung Received Received
  38-EP Demographic, Clinical and Molecular Landscape of Myeloid Malignancies in a Developing Country: A Pilot Study Wai Feng Lim Received Received
  39-EP Molecular Signature of Myeloid Malignancies in a Developing Country: 22-gene Next-Generation Sequencing Panel Wai Feng Lim Received Received
  40-EP VENETOCLAX AND AZACITIDINE TREATMENT IN AML BARRIERS TO OUTPATIENT MANAGEMENT Ben Macleod Received Received
  41-EP Management of chronic myeloid leukaemia in the UK: Results from the ADAPT 2.0 survey Vanesa Martinez Lopez Received Received
  42-EP Spectrum of BCR::ABL1 Tyrosine Kinase Domain mutations in Imatinib Resistant Chronic Myeloid Leukaemia Patients. Ahmed Ibrahim Received Received
  43-EP Primary Thrombocytosis in Children Dr. Chikosolu Yvonne Okiche Received Received
  44-EP The bone marrow T-cell receptor repertoire does not predict treatment-free remission in chronic myeloid leukaemia Shaun David Patterson Received Received
  45-PP Nemtabrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Open-Label, Phase 3 BELLWAVE-010 Study Charlotte Brennan Received Received
  46-PP Nemtabrutinib in Untreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Phase 3 BELLWAVE-011 Study Charlotte Brennan Received Received
  46-EP Evaluating Metabolic and Autophagic Changes in Imatinib-Resistant Chronic Myeloid Leukemia Cells Ezzahra Rachid Received Received
  47-EP Review of Post-marketing Safety Data for EPYSQLI (SB12), Biosimilar to Reference Eculizumab, in Pregnant Women Roochi Trikha Received Received
  49-EP Double-Class Exposed Patient and Carer Experiences of Living with Multiple Myeloma Noreen Ali Received Received
  50-EP Newly Diagnosed Patient and Carer Experiences of Living with Multiple Myeloma Noreen Ali Received Received
  51-EP Challenges hinder compliance with BSH recommendations for diagnosis and treatment of transplant-eligible high-risk myeloma patients Peter Bennett Received Received
  52-EP The Source of Heart and Circulatory Disease and Related Events in Myeloma: A Systematic Review Romi Carriere Received Received
  53-EP Optimising the diagnostic pathway for myeloma patients in a tertiary haematology centre Richard Cassar White Received Received
  55-EP Spinal Involvement in Multiple Myeloma: a Comparison of Current Practise in CAVUHB with NICE Guidelines Anest Edwards Received Received
  57-EP Risk Stratification in Multiple Myeloma in the UK A mixed methods study Sarah Galley Received Received
  58-PP A Matching-Adjusted Indirect Comparison: Loncastuximab Tesirine versus Glofitamab in Relapsed/ Refractory DLBCL Koo Wilson Received Received
  59-EP Establishing a Joint Renal-Haematology Service for Monoclonal Gammopathy of Renal Significance: A Feasibility Study Gerard Gurumurthy Received Received
  60-EP Patient and Staff Experience of Ambulatory BCMA T-cell Engager Antibody Step-up Dosing: The Leeds Experience Lindsay Hankey Received Received
  61-EP Dara-RVd in Newly Diagnosed Multiple Myeloma: Real-World Clinical Practice Interim Data Stanislav Kamyshanov Received Received
  62-EP MRD-Adaptive Strategy as the Therapeutic Approach for Newly Diagnosed Multiple Myeloma: Precursory Results Stanislav Kamyshanov Received Received
  63-EP Evaluating Monoclonal Gammopathy of Undetermined Significance Referral Accuracy: Reducing Over- and Under-Referrals Moein Karbalaeian Received Received
  63-PP Iptacopan demonstrates long-term efficacy and safety in patients with paroxysmal nocturnal haemoglobinuria (PNH):APPLY_PNH Austin Kulasekararaj Received Received
  64-EP Rethinking Monoclonal Gammopathy of Undetermined Significance Follow-up: Strengthening Guideline Compliance and Reducing Secondary Care Burden Moein Karbalaeian Received Received
  65-EP Deliverability of D-VTd in the Treatment of Multiple Myeloma Harry Kneale Received Received
  66-EP Impact of Argentinian Tango on Psychological Well-being and Clinical Outcomes in Patients with Multiple Myeloma Pavel KOTOUCEK Received Received
  67-EP Impact of Elranatamab on Immunoglobulin Levels in a Real-World Multiple Myeloma Patient Cohort Craig Lennie Received Received
  68-EP Optimizing Monoclonal Gammopathy of Undetermined Significance follow-up care:Review of Data from a Tertiary Hematology Centre Soe Maung Received Received
  68-PP Retrospective analyses of NLPHL outcomes in the Thames Valley Xiao-Yin Zhang Received Received
  69-EP Semi-automated patient videos to address knowledge gaps regarding anti-coagulation with immunomodulatory drugs in multiple myeloma Kathryn McVinnie Received Received
  70-EP The Efficacy of Bortezomib-Based Regimen on Responses and Survival in Newly Diagnosed Multiple Myeloma patients Ahmed Ibrahim Received Received
  71-EP Vaccination uptake among myeloma patients diagnosed in 2022 and 2023 within a major healthcare system. Chinedu Onwuatuogwu Received Received
  72-EP Quality Improvement Project on Rationalising Investigation and Follow-Up for Monoclonal Gammopathy of Undetermined Significance Patients Sohum Patel Received Received
  73-EP Uncovering Disparities and Opportunities: Identifying CAR T Therapy-Eligible patients in a Real-World Multiple Myeloma Population Louise Potter Received Received
  74-PP Lotis-5: Phase 3 Randomized Study of Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in R/R DLBCL Pamela Mckay Received Received
  74-EP Developing a method evaluating quality-of -life of patients living with monoclonal gammopathy of undefined significance indra ramasamy Received Received
  75-EP Introduction of a semi-automated monoclonal protein risk stratification process: a Rotherham experience James Taylor Received Received
  78-EP Hodgkin Lymphoma in Older Patients (HoOP)- A Retrospective Study Aising Barrett Received Received
  79-EP 18F-FDG-PET scanning following T-cell deplete RIC allogeneic transplantation for relapsed Hodgkin Lymphoma: a single-centre experience Adrian Bloor Received Received
  80-EP The Role of Novel Thienopyridine Compounds as Anti-Cancer Agents via Disruption of the Cell Cycle Christopher Broughton Received Received
  81-EP Efficacy and tolerability of Pola-R-CHP versus R-CHOP in first-line DLBCL treatment: A Real-World data review Victoria Calvert Received Received
  82-EP Epcoritamab Monotherapy in Relapsed/Refractory Chronic Lymphocytic Leukemia: EPCORE CLL-1 Expansion and Optimization Data Kayla Smull Received Received
  83-EP Introducing Bi-Specific Antibody Therapy in managing high-grade B-Cell Non-Hodgkins Lymphoma in a Regional Service Ewan Deans Received Received
  84-EP Outcomes for relapsed/refractory DLBCL patients aged =80 years treated with Polatuzumab Vedotin, Bendamustine and Rituximab Amie Drinkwater Received Received
  85-EP Prehabilitation improving lymphoma outcomes Rona Eade Received Received
  86-EP Survivorship Clinic Improves Trans-thoracic Echocardiogram Follow up for Anthracycline Induced Cardiomyopathy zac forbes Received Received
  87-EP Contemporary Therapy Outcomes with Brentuximab Vedotin, Bendamustine and Checkpoint Inhibitors in Relapsed/Refractory Classical Hodgkin Lymphoma. Mia Giles Received Received
  89-PP KEYNOTE-B68 Update: Pembrolizumab Every 6 Weeks in Classic Hodgkin Lymphoma or Primary Mediastinal B-Cell Lymphoma Charlotte Brennan Received Received
  90-PP WAVELINE-003: Zilovertamab Vedotin Plus Standard of Care in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Charlotte Brennan Received Received
  90-EP LOTIS-7: Phase 1b Study of Loncastuximab Tesirine with other agents in relapsed/refractory B-cell NHL Katja Fraser Received Received
  91-EP A Retrospective study Evaluating Management of T-cell Large Granular Lymphocytic Leukaemia in a University Hospital Mohammad Kamrul Hassan Majumder Received Received
  92-EP Secondary HLH in a paediatric patient with trisomy 21: a tortuous diagnostic journey. Michail Matalliotakis Received Received
  93-EP Defining Fitness and Understanding Frontline Treatment Choice in Chronic Lymphocytic Leukaemia: A Modified Delphi Panel Talha Munir Received Received
  94-EP A Retrospective Study of Prevalence of CXCR4 Mutations in Patients with Waldenstroms Macroglobulinemia in Singapore AMAZE JOY TULLAO ONG Received Received
  95-EP A Case Report Showing Low-dose Ciclosporin Can Successfully Treat Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma Neil Chauhan Received Received
  96-EP Differences in healthcare resource utilisation between 3L DLBCL treatments: A UK HCP survey Molly Paffett Received Received
  97-EP Bleeding and Thrombotic Events Following CAR T Cell Therapy: A Three-Year Single-Centre Retrospective Study Sohum Patel Received Received
  99-EP Retrospective review of radiologically identified lymphadenopathy. Elizabeth Ryan Received Received
  100-EP Retrospective Review of Real-World Data on Use of R-POLA-CHP Chemotherapy for Large B Cell Lymphoma Hannah Sadler Received Received
  101-EP Splenectomy Links Guillain-Barré Syndrome, Autoimmune Haemolysis and EBV viraemia: Unveiling a Hidden Diagnosis Pranav Santhosh Kumar Received Received
  101-PP Diagnostics and Monitoring in Chronic Myeloid Leukaemia Treatment in the UK: ADAPT 2.0 Survey Darina Hickey Received Received
  102-EP Retrospective study evaluating diagnostic criteria of T-cell Large Granular Lymphocytic Leukaemia in a University Hospital Htet Htet Myo Set Received Received
  103-EP Therapeutic Equivalence of Biosimilar and Innovator Rituximab in Non-Hodgkins Lymphoma: A Systematic Review and Meta-analysis Nitin Sood Received Received
  104-EP Proposed Standard of Care for Active Monitoring in Waldenström Macroglobulinemia From a UK-Wide Patient-Expert Collaboration G. Isabella Received Received
  105-EP Monitoring Cardiovascular Risk Factors for patients on Bruton Tyrosine Kinase Inhibitors sharing improvements in practice. Anna Elliott Received Received
  106-EP Challenges to establishing a tafasitamab compassionate use scheme in an NHS trust: a pharmacy review Clayton Wong Received Received
  107-PP VAYHIT3: Phase 2 Study of Ianalumab in Previously Treated Patients With Primary Immune Thrombocytopenia Nichola Cooper Received Received
  109-EP Infantile Giant Cell Hepatitis with Autoimmune Hemolytic Anemia in a Sri Lankan Infant Arunath Visvalingam Received Received
  110-EP Genetic Analysis using the R92 Panel of Rare Anaemia and Referral Submission Quality Jessica Coyle Received Received
  111-EP Pain management in Sickle Cell Disease, Audit of Fluid and Analgesia therapy (PACIFY study) Michael Egolum Received Received
  112-PP Efficacy and safety of intensive pegcetacoplan dosing for the treatment of acute haemolysis in patients with paroxysmal nocturnal haemoglobinuria Sana Yaar Received Received
  113-EP Antenatal haemoglobinopathy screening: Opportunity for Targeted Newborn Screening for Sickle Cell Disease in Northern Nigeria Adama Ladu Received Received
  116-EP The Complex Relationship Between Iron Deficiency Anaemia and Sickle Cell Disease Helena Usuanlele Received Received
  117-EP Comparing paediatric sickle cell pain protocol adherence with national and trust guidelines in A&E. Yang Yang Wang Received Received
  118-EP Using wearable health monitors in cancer research: Lessons from the EMBRaCE-GM study. Mona Asslan Received Received
  120-EP The influence of Knowledge, Attitudes and Practice on adherence to SCD Guidelines: a scoping review Mmamulatelo Siame-Mumba Received Received
  121-EP Treatment Escalation Plan Completion in Haematology Inpatients in Aberdeen Royal Infirmary: A Quality Improvement Project Sophie White Received Received
  122-EP COVID-19 infection in adult patients with hematological malignancies In Oman Nema Al Masroori Received Received
  123-EP Approach to paediatric HLH in 2025: who warrants chemotherapy in the era of immunomodulation ? Joanna Collins Received Received
  124-EP Use of incentive spirometry to prevent Acute Chest Syndrome in patients with Sickle Cell Disease Tasneem Elkanzi Received Received
  125-EP Role of Therapeutic plasma exchange in Pneumococcal associated Hemolytic uremic syndrome Nirmalie Fonseka Received Received
  126-EP Avatrombopag use in Patients with Immune Thrombocytopenia: Interim Analysis of the Phase 4 ADOPT Study Vickie McDonald Received Received
  127-EP Retrospective audit on comparison of local practice of ITP management with 2019 international consensus report Arunodaya Mohan Received Received
  127-PP Collaborative initiative with the National PNH Service: Survey results from a pegcetacoplan Patient Support Programme Sana Yaar Received Received
  128-PP Why would you call an ambulance for a nosebleed? The reality of haemophilia emergency care. Ranjit Nagra Received Received
  128-EP A rare case of bone marrow failure syndrome: TERC variant telomeropathy consistent with Dyskeratosis Congenita. Sumitha Niyomi Nanayakkara Received Received
  129-PP Injection-Site-Reactions in Adults With Paroxysmal Nocturnal Haemoglobinuria Receiving Subcutaneous Pegcetacoplan for Up to 3 Years Sana Yaar Received Received
  132-PP Neutropenic Sepsis in Patients Admitted at SAMOC (Sir Anthony Mamo Oncology Centre) - Malta Karen Cutajar Received Received
  132-EP Nurse Led Thromboprophylaxis Service for Women at 28 Weeks Gestation at High Risk of VTE Jo Webb Received Received
  133-EP Effectiveness of Iron Carboxymaltose in Maternity Patients for the Treatment of Anaemia Amy Somerville Received Received
  134-EP An Audit of Perioperative Transfusion Practices in Pediatric Sickle Cell Disease Patients at Sidra Medicine,Qatar Salwa Syed Sadaqat Ali Received Received
  135-EP Alloimmunization in Children with Sickle Cell Disease at Sidra Medicine, Qatar Salwa Syed Sadaqat Ali Received Received
  137-EP Isolated Bone Marrow Mastocytosis with hymoneptra allergic reaction Hansini Dassanayake Received Received
  138-EP Distribution of MNSs Blood Group Antigens Of Individuals Within Calabar Metropolis, Cross River State, Nigeria DISTRIBUTION OF MNSs BLOOD GROUP ANTIGENS OF INDIVIDUALS WITHIN CALABAR METROPOLIS, CROSS RIVER STATE, NIGERIA. Joyce Etura Received Received
  139-EP Comparison of ABO/RhD blood groups distribution among DGH and NHSBT donors over 12 months Thais Ferrari Gersogamo Received Received
  140-EP Determining Optimal Haemoglobin Thresholds for Blood Donor Deferral: A Study in a Multi-Ethnic Developing Country Melissa Friday Received Received
  141-EP Optimising Albumin Use Across Disciplines at University Hospitals of North Midlands: Quality Improvement Project Report Syed Aaquil Hasan Received Received
  142-EP Paediatric Morphology: A Case of Haematological Toxicity Associated with Sodium Valproate Joanne Hayter Received Received
  143-EP Assessment of the bodys response to blast injury using haematological ratios. Inesa Iefimova Received Received
  144-EP The Application of Autologous Platelet-Rich Fibrin and Platelet-Rich Plasma in Managing a Pathological Mandibular Fracture Susudu Jayanetti Received Received
  145-EP Anti-U Antibodies in Pregnancy: Immunohematology Insights. Gauri Jayasinghe Received Received
  146-EP Audit on Indications for Therapeutic Plasma Exchange practice in Lady Ridgeway Hospital for Children SriLanka. Gauri Jayasinghe Received Received
  147-EP Antibody against high-frequency antigen during pregnancy: Scenario of Anti-Inb antibody in University Hospitals of Leicester. Gauri Jayasinghe Received Received
  148-EP Hemolytic Disease of Fetus and Newborn due to Anti Cw and Anti Jka antibodies. Gauri Jayasinghe Received Received
  148-PP Clinical Knowledge of Sickle Cell Disease among Doctors at a Tertiary Hospital in West Midlands Samadhi Wickramasinghe Received Received
  149-EP Rare Antibody causing Hemolytic Disease of Newborn: Scenario of Anti-Coa in University Hospitals of Leicester. Gauri Jayasinghe Received Received
  150-EP Relationship between patient education and knowledge on INR control and INR values in Warfarin Therapy Chitranga Kariyawasan Received Received
  151-EP The impact of Serum Ferritin, on HbA2 levels in Thalassemia Screening a single center experience Chitranga Kariyawasan Received Received
  153-EP Rituximab-Induced Neutropenia: A Case Report on Effective Use of Buffy Coat Transfusion and GCSF Narmada Manawasinghe Received Received
  154-EP A Rare Case of C3d-positive Warm Autoimmune Hemolytic Anemia in a Pediatric Patient Narmada Manawasinghe Received Received
  155-EP Reflex testing of intrinsic factor antibody for positive parietal cell antibody in pernicious anaemia Daisy Metcalfe Received Received
  156-EP Development of Algorithm and Clinical Decision support system for Laboratory investigation of Thrombocytopenia sateesh kumar Nagumantry Received Received
  157-EP Assessing Safety of Blood Donations from Smokers: A Comparative Analysis of Biomarkers and Hematological Parameters Ifeyinwa Okafor Received Received
  158-EP Demographic characteristics of blood and blood-components transfusion recipientsand pattern of blood utilization in Nigeria Henshaw Okoroiwu Received Received
  159-EP A Case of Thalassemia Intermedia With Alloantibodies Jka and E: Challenges in Transfusion Management Purshotam Paudel Received Received
  160-EP Mixed Autoimmune Hemolytic Anemia in Children Managed With Steroids and PRBC Transfusion: a Case Report Purshotam Paudel Received Received
  161-EP The Importance of Recognising TACO in the Management of Complex Transfusion Reactions. Malaika Perchard Received Received
  163-EP A single centre service evaluation of patient blood management pathways for optimising haemoglobin pre-operatively. Shashi Rajnarinesingh Received Received
  164-EP Patterns and Outcomes of Transfusion-dependant -Thalassemia (TDT) Children Over Five Years in Uttarakhand India Manish Raturi Received Received
  165-EP Validation of an anti-Xa assay to monitor high heparin concentrations in patients undergoing cardiothoracic surgery. Claire Rowlandson Received Received
  166-EP Results of Intrauterine Transfusions in prenatal anemia---Seguridad Transfusional Intrauterina en madres aloinmunizadas y feto con anemia prenatal. Carolina Carmen Sánchez-Ramos Received Received
  167-EP Reducing platelet wastage: an audit of platelet use and wastage at Rotherham General Hospital Andrei Serov Received Received
  168-EP Comparative Analysis of DNA Concentration Determination for Qualitative and Quantitative Assessment Obtained of Samples Nataliya Shurko Received Received
  169-EP Learning from EQA: When the dog bites Andrea Teuchert Received Received
  170-EP When to Test for Thrombophilia? Understanding the Implications of Implementing the 2022 Guidelines Shabnam Banerjee Received Received
  171-EP Establishing Venous Thromboembolism Prevention Champions at a District General Hospital Alexandra Butler Received Received
  172-EP Single site experience of enoxaparin vs unfractionated heparin thromboprophylaxis in patients admitted to renal wards Rachel Clapham Received Received
  173-EP Case report: Apixaban Absorption in a Patient with Deep Vein Thrombosis and Previous Gastric Bypass Rebecca Cloudsdale Received Received
  174-EP Deep Vein Thrombosis and Nitrous Oxide Abuse: a Case Series Rebecca Cloudsdale Received Received
  175-EP INR self-testing revisited: Improving the patient experience in a NHS trust Niamh Cole Received Received
  176-EP Ianalumab in Patients with Primary Immune Thrombocytopenia (VAYHIT1/VAYHIT2) and Warm Autoimmune Haemolytic Anaemia (VAYHIA) Devi Prathyusha Nadakuditi Received Received
  177-EP Immune Thrombocytopenia in a Developing Country: Insights from a Tertiary Care Private Institution Christopher Ming Yu Foo Received Received
  177-PP Investigation and Management of Neutropenia Referrals in Area with a High Prevalence of Afro-Caribbean patients Priya Sriskandarajah Received Received
  178-EP An in vitro study on prophylactic doses of anticoagulants in coagulation factor deficiencies Alex Gatt Received Received
  179-PP Impact of Sickle Cell Disease Patients on Healthcare System; A Single Institutional Retrospective Observational Study Nadeeka Makewitage Received Received
  179-EP Single centre experience on direct acting oral anticoagulant levels and clinical outcomes Richard Hinton Received Received
  180-EP Anticoagulation treatment ion in Thrombosis management for patients with Myeloproliferative Neoplasms at Whipps Cross Hospital Nalika Jayasekara Received Received
  181-EP Anticoagulation Treatment of Patients with Cerebral Venous Sinus Thrombosis Sashini Mariathasan Received Received
  181-PP Rare Blood, Rarer Genes: Mumbais First Réunion Phenotype Blood Donor with novel FUT Gene Mutations Lincy Jacob Received Received
  182-PP Patient Experience of Treatment Duration Options in Relapsed/Refractory Chronic Lymphocytic Leukaemia: UK Qualitative Study (ELECTRIC) Dima El-Sharkawi Received Received
  182-EP The Management of Acute Heparin Induced Thrombocytopenia (HIT) in Patients Listed for Cardiac Transplant Lindsey McGuire Received Received
  183-EP Safety Audit of the Off-Label Use of Apixaban in Nephrotic Syndrome. Jayna Mistry Received Received
  184-EP Using artificial intelligence to prompt early intervention by thrombosis nurse specialists in acute venous thromboembolism Kate Musgrave Received Received
  185-EP Heparin-induced Thrombocytopaenia (HIT)-associated Anaphylactoid Reactions Following Subcutaneous Low Molecular Weight Heparin William Phipps Received Received
  186-EP An Audit to Assess Therapeutic Unfractionated Heparin (UFH) for Hospital Adult Inpatients Clarissa Pui Received Received
  187-EP A Quarterly Audit to Assess Venous Thromboembolism Prevention Management in Hospital Inpatients Clarissa Pui Received Received
  188-EP Testing of Von Willebrand Antigen and Activity in Pregnancy and Labour Caitlin Rice Received Received
  189-EP Management of bleeding disorders in pregnant women: a single tertiary-centre experience Caitlin Rice Received Received
  190-EP Venous Thromboembolism in Cardiac Surgery: Comparing Emergency with Elective Admissions Huw Rowswell Received Received
  191-EP Venous Thromboembolism in Obstetric Patients 2014 2024: Comparison with all VTE events Huw Rowswell Received Received
  192-EP Audit of a Multidisciplinary Follow-Up Pathway of Acquired Haemophilia A Gargi Sharma Received Received
  193-EP Emicizumab for Multi-Refractory Acquired Haemophilia A Laith Tafesh Received Received
  194-PP Using Artificial Intelligence to Identify Patient Emotions Across The Multiple Myeloma Diagnosis and Treatment Journey Noreen Ali Received Received
  196-PP Zilovertamab Vedotin Plus R-CHP in Untreated Diffuse Large B-Cell Lymphoma: Phase 2 waveLINE-007 Trial Charlotte Brennan Received Received
  199-PP An audit demonstrating a safe and cost-effective model of out-patient intensive chemotherapy for acute leukaemia. Amy Todd Received Received
  201-PP A Single-Centre Experience of Methotrexate for the Management of Pure Red Cell and Pure White Cell Aplasia Laura Batey Received Received
  206-PP Efficacy and patient satisfaction in ITP patients switching to Avatrombopag from Eltrombopag or Romiplostim Peyman Adjamian Received Received
  208-PP Pharmacokinetic and Efficacy Assessment of a New Fibrinogen Concentrate in Patients with Congenital Fibrinogen Deficiency Eugenio Rosado Received Received
  213-PP Practical Insights into Managing Iron Deficiency Anaemia at UCLH Kate OConnell Received Received
  218-PP Machine Learning-Based Prediction of Hospitalization Risk in Multiple Myeloma Patients Ceri Bygrave Received Received
  220-PP A Randomised Trial of Intermediate-Dose Heparin versus Standard-Dose Thromboprophylaxis in Critically Ill Patients with COVID-19 Charlotte Bradbury Received Received
  224-PP Involving patients in the development of a Patient Initiated Follow up (PIFU) scheme in Wales Charlotte bloodworth Received Received
  226-PP Characterisation of Clinically Significant Breakthrough Haemolysis in Patients With Paroxysmal Nocturnal Haemoglobinuria Treated With Pegcetacoplan Sana Yaar Received Received
  237-PP Sickle cell trait as a hematological contribution to vascular cognitive impairment and dementia: Hyacinth Hyacinth Received Received
  273-PP Evaluating Adherence to Updated BSH and NICE Guidelines for Polycythaemia Vera and Secondary Erythrocytosis Management. Kashif Waqas Received Received
  291-PP Low Rates of Utilisation of CNS-directed Prophylaxis in Diffuse Large B-cell Lymphoma: Measuring the Impact Samuel Wiltshire Received Received
  293-PP Clinical Outcomes for Patients Receiving First-line Pola-R-CHP for Large B-cell Lymphoma Treated at Gloucestershire Hospitals Mahina Baloch Received Received
  307-PP The utility of bone marrow assessment in Consultative Haematology Tendaishe Mutize Received Received
  340-PP Herpes zoster incidence rates in adults with haematological malignancies: a retrospective cohort study (20122019) Lyes Derouiche Received Received
  353-PP Anticoagulation Decisions at the End of Life: A Survey of UK Clinicians. Thomas Shevlin Received Received
  354-PP Reporting haemostasis assays in IU/dL: recommendations from the BSH, UKHCDO and UK NEQAS (Blood Coagulation) Ian Jennings Received Received
  357-PP Efanesoctocog Alfa in Adults/Adolescents with Haemophilia A: European Results from the XTEND-ed Second Interim Analysis Jayashree Motwani Received Received
  362-PP Impact of updated guidance and implementation of a local Pulmonary Embolism Response Team (PERT) Lara Roberts Received Received
  377-PP Duration of Caplacizumab Therapy for Acute Immune-Mediated Thrombotic Thrombocytopenic Purpura (iTTP) Rebecca J Shaw Received Received
  383-PP Simultaneous IgG and IgM Platelet Antibodies Causing Acquired Thrombocytopenia, Platelet Clumping and Spontaneous Bleeding Rebecca J Shaw Received Received
  389-PP A UK review of the treatment of idiopathic multicentric Castlemans disease (iMCD) with siltuximab Janine Qasim Received Received
  398-PP What Bacteria Cause Central Line-associated Bloodstream Infections in a Paediatric Population of Haemophilia? Aditya Chezhian Received Received
  400-PP Impact of Nursing Engagement to Improving Fever-to-Needle Time in St. Bartholomews Hospital Haematology-Oncology Department Greal Huypungco Received Received
  406-PP The Efficacy and Safety of Avatrombopag for the Treatment of Children with Immune Thrombocytopenia (AVA-PED-301) Peyman Adjamian Received Received
  432-PP The Use of Cellavision to Facilitate The Referral of Blood Films to the Consultant Haematologist Robert Grainger Received Received
  437-PP Real-World Treatment Outcomes of Venetoclax in Acute Myeloid Leukemia in Great Britain (ARC) Hanna Kew Received Received
  441-PP RADAR: An International Trial Comparing ABVD with Brentuximab Vedotin plus AVD in Limited-Stage Hodgkin Lymphoma Pip Patrick Received Received
  445-PP Real-Time Monitoring of Pain Variability in Sickle Cell Disease: Patient-Reported Outcome Links to Vaso-Occlusive Crises Kim Summers Received Received
  446-PP Efficacy/Safety of the BTK Degrader NX-5948 in Waldenström macroglobulinemia: An Ongoing Phase 1a/b Study Lee Miller Received Received
  449-PP Audit on Improving the Diagnosis and Management of Haemophagocytic lymphohistiocytosis (HLH) at Leeds Teaching Hospitals. Amany Ihab Mohamed Received Received
  453-PP Pathology Portal in Haematology Training: a Tool to Standardise and Harmonise Morphology Skills across UK. Amany Ihab Mohamed Received Received
  456-PP Comparison of pre and post treatment concerns for Lymphoma patients at a London NHS Trust. Karen Stanley Received Received
  462-PP Epcoritamab Monotherapy for Relapsed or Refractory Large B-Cell Lymphoma: 3-Year Follow-Up From EPCORE NHL-1 Kayla Smull Received Received
  464-PP Learning from Experience: The Use of Andexanet Alfa in the Management of Life-Threatening Gastrointestinal Bleeding Sarah Wheeldon Received Received
  466-PP Fixed-Duration Epcoritamab R-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: EPCORE NHL-2 Update Kayla Smull Received Received
  468-PP Fixed-Duration Epcoritamab R-Mini-CHOP in Newly Diagnosed Diffuse Large B-Cell Lymphoma: EPCORE NHL-2 Update Kayla Smull Received Received
  481-PP Real-Time Treatment Impact Tracking: Implications for the Feasibility of Remote Digital Monitoring in Waldenstrom Macroglobulinemia Kim Summers Received Received
  497-PP SECURE Study: Incidentally Detected MGUS Patients Have Comparable Depression Anxiety Rates to UK General Population Elizabeth Knight Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Katarina Gluic
Hours: Mon-Thu 8:30-17:00 Fri 8:30-15:00
06:00
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments

 

65th Annual Scientific Meeting

 

27-29 April Glasgow
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 27/04/2025 TO 27/04/2025
Poster
Gallery
Upload
Poster
Featured Poster
Vote poster
Poster Discussion
Forum
                  




PosterSessionOnline
Logo Draft
 
Logo Cert